Prognostic significance of markers of thrombin generation in the acute and chronic phases of non cardioembolic ischemic stroke

Minerva Cardioangiologica

Volumn 48, Issue 11, 2000, Pages 349-354

  Soncini, M ^b   Gasparini, P ^b   Lorena, M ^b   Motta, A ^a   Cimminiello, C ^b  

^a SAN CARLO BORROMEO HOSPITAL   (Italy)

^b NONE

Author keywords

Blood coagulation; Cerebral ischemia; Cerebro vascular disorders; Prothrombin fragment 1; Prothrombin fragment 2; Thrombin antithrombin complex

Indexed keywords

ANTITHROMBIN III; ANTITHROMBIN III PROTEASE COMPLEX; ANTITHROMBIN III-PROTEASE COMPLEX; BIOLOGICAL MARKER; PEPTIDE FRAGMENT; PEPTIDE HYDROLASE; PROTEIN PRECURSOR; PROTHROMBIN; PROTHROMBIN FRAGMENT 1;

ACUTE DISEASE; AGED; ARTICLE; BLOOD; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; CHRONIC DISEASE; FEMALE; HUMAN; MALE; MIDDLE AGED; PROGNOSIS;

ACUTE DISEASE; AGED; AGED, 80 AND OVER; ANTITHROMBIN III; BIOLOGICAL MARKERS; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; CHRONIC DISEASE; FEMALE; HUMANS; MALE; MIDDLE AGED; PEPTIDE FRAGMENTS; PEPTIDE HYDROLASES; PROGNOSIS; PROTEIN PRECURSORS; PROTHROMBIN;

EID: 0034328730     PISSN: 00264725     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Feinberg WM, Bruck DC, Ring ME, Corrigan JJ Jr. Hemostatic markers in acute stroke. Stroke 1989;20:592-7.
2. Tohgi H, Kawashima M, Tamura K, Suzuki H. Coagulation-fibrinolysis abnormalities in acute and chronic phases of cerebral thrombosis and embolism. Stroke 1990;21:1663-7.
3. Landi G, D'Angelo A, Candelise L, Mannucci PM, Nobile Orazio E, Morabito A. Hypercoagulability in acute stroke. Neurology 1987;37:1667-71.
4. Yamazaki M, Uchiyama S, Maruyama S. Alterations of haemostatic markers in various subtypes and phases of stroke. Blood Coagul Fibrinol 1993;4:707-12.
5. Takano K, Yamaguchi T, Uchida K Markers of hypercoagulable state following acute ischemic stroke. Stroke 1992;23:194-8.
6. Landi G, Barbarotto R, Morabito A, D'Angelo A, Mannucci PM. Prognostic significance of fibrinopeptide A in survivors of cerebral infarction. Stroke 1990;21:424-7.
7. Whisnant JP, Basford JK, Bernstein EF. Special report from the National Institute of Neurological Disorders and Stroke Classification of cerebrovascular diseases III. Stroke 1990;21:637-76.
8. Gustafsson C, Blomback M, Britton M, Hamsten A, Svensson J. Coagulation factors and the increased risk of stroke in nonvalvular atrial fibrillation. Stroke 1990;21:47-51.
9. Pop G, Meeder HJ, van Oudenaarden W, van Latum JC, Koudstaal P. Hemostatic activity in patients with a transient ischemic attack or minor ischemic stroke with or without chronic non-valvular atrial fibrillation. Cerebrovasc Dis 1993;3:350-6.
10. Merlini PA, Bauer KA, Oltrona L, Ardissino D, Cattaneo M, Belli C et al. Persistent activation of coagulation mechanism in unstable angina and myocardial infarction. Circulation 1994;90:61-8.
11. Bamford J. Clinical examination in diagnosis and subclassification of stroke. Lancet 1992;339:400-2.
12. Bauer KA, Rosemberg RD. The pathophysiology of the prethrombotic state in humans: insight gained from studies using markers of hemostatic system activation. Blood 1987;70:343-50.
13. Clauss A. Gerinnungshiysiologpsche Schellmethode Zur Bestimmung des Fibrinoges. Acta Haematol 1967:237-46.
14. nd edition. Philadelphia: WB Saunders Co, 1984:771-806.
15. Ono N, Koyama A, Suehiro A, Oku K, Fujikake K, Kakishita E. Clinical significance of new coagulation and fibrinolytic markers in ischemic stroke patients. Stroke 1991;22:1369-73.
16. Jafri SM, Eberhard F, Masura J, Goldstein S. Effects of warfarin on markers of hypercoagulability in patients with heart failure. Am Heart J 1997;134:27-36.
17. Grau AJ, Ruf A, Vogt A, Lichy C, Buggle F, Patscheke H et al. Increased fraction of circulating activated platelets in acute and previous cerebrovascular ischemia. Thromb Haemost 1998;80:298-301.
18. Carter AM, Catto AJ, Bamford JM, Grant PJ. Gender-specific associations of fibrinogen Bbeta 448 polymorphism, fibrinogen levels, and acute cerebrovascular disease. Arterioscler Thromb Vasc Biol 1997;17:589-94.
19. Mannucci P, Bottasso B, Tripodi A, Bonomi A. Prothrombin fragment F1+2 and intensity of treatment with oral anticoagulants. Thromb Haemost 1991;66:741.
20. Conway E, Bauer KA, Barzegar S, Rosemberg RD. Suppression of the hemostatic system activation by oral anticoagulants in the blood of patients with thrombotic diatheses. J Clin Invest 1987;80:1535-44.
21. EAFT (European Atrial Fibrillation Trial) Study Group. Secondary prevention in nonrheumatic atrial fibrillation after transient ischaemic attack or minor stroke. Lancet 1993;349:1955-62.
22. International Stroke Trial Collaborative Group. The International Stroke Trial (IST). A randomised trial of aspirin, subcutaneous heparin, both, or neither among 19.435 patients with acute ischaemic stroke. Lancet 1997;349:1569-81.
23. Algra A on behalf of the SPIRIT Study group. SPIRIT: Bleeding complications in patients after cerebral ischemia treated with anticoagulant drugs. Stroke 1997;28: 231.